Calliditas’ Phase IIb trial of PBC treatment meets primary endpoint
Setanaxib was also found to be well-tolerated in the trial.
Clinical Trials
Highlands Oncology and Paradigm report 45% rise in Northwest Arkansas trials
Eisai adopts Medidata’s AI-driven platform for clinical trials
Viridian completes subject enrolment for Phase III trial of TED treatment
Autobahn secures $100m to advance trials of depression treatment
Inimmune doses first subject in Phase I solid tumour trial
Sage and Biogen’s SAGE-324 shows no benefit in essential tremor trial
Pfizer reports positive data from trial of gene therapy for haemophilia A
